Showing Results for: “diabetes”

American Diabetes Association Symposium Shows Patients with Type 1 Diabetes Experienced Insulin Independence and Elimination of Severe Hypoglycemic Events with Novel Therapy Today, new data from the Phase 1/2 FORWARD clinical study of the VX-880 islet cell therapy was presented at a symposium at the American Diabetes Association® (ADA) 84th Scientific Sessions in Orlando, FL. The results demonstrated that VX-880 reduced or eliminated the need for insulin use in patients with type 1 diabetes (T1D), indicating that VX-880 stem cell-derived islets can restore physiological islet function and

Yesterday, the U.S. House of Representatives passed the Affordable Insulin Now Act, which would cap the monthly out-of-pocket cost of insulin at $35 for Americans with commercial insurance, group health plans and Medicare. The American Diabetes Association ® (ADA) has been the leading advocate for state and national insulin co-pay caps, resulting in the enactment of out-of-pocket limits for insulin in 20 states and the District of Columbia. We've seen exactly how much Americans with diabetes who rely on insulin stand to benefit from reducing the cost to patients of this live-saving drug. This

Cycling event raises funds to support diabetes research, local programming, and advocacy efforts The American Diabetes Association ® (ADA) is thrilled to host the 2025 Tour de Cure ®: Minnesota at Boom Island Park on May 31. This cycling fundraising event raises funds so the ADA can fight for all people living with diabetes—one of the fastest growing chronic diseases in the world.  Nationwide, over 38 million people have diabetes, and every 26 seconds, someone new is diagnosed. Approximately 452,000 adults in Minnesota, or 9% of the adult population, have diagnosed diabetes. Every year, an

Eliminating copays for medication would reduce the financial burden millions are facing during this challenging time The American Diabetes Association (ADA) applauds Speaker of the House Nancy Pelosi for calling for zero-dollar copays for medication for seniors on Medicare as a response to the coronavirus (COVID-19). Tracey D. Brown, Chief Executive Officer of the ADA, issued the following statement: “The cost of insulin for those living with diabetes can be debilitating as people are facing reduced paychecks and unemployment as a result of the coronavirus (COVID-19), making it that much

The American Diabetes Association® (ADA) is excited to have Paul Engola, Leidos’ Chief Human Resources Officer & Head of Business Partnerships, as the honorary chair for this year's Virtual Northern Virginia (NOVA) Tour de Cure to be held on Sunday, October 18, 2020. The ADA encourages everyone to cycle, run or walk on that date in support of the 34 million Americans living with diabetes. Leidos is a strong supporter of the ADA, leading the way with a National Tour de Cure team participating in cities all across the country. The ADA is proud to have Paul lend his name to raise awareness about

Expanded results from the first-of-its-kind clinical trial explores the use of SGLT2 inhibitor for COVID-19 patients with hypertension, cardiovascular disease, heart failure, type 2 diabetes, or chronic kidney disease DARE-19 is the first large randomized clinical trial to assess sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with and without type 2 diabetes hospitalized with COVID-19. Additional findings from the trial were presented today at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Patients with cardiometabolic risk factors, including

“The American Diabetes Association (ADA) applauds Governor John Carney for signing Senate Bill 107 to eliminate cost sharing for insulin pumps for state-regulated health plans, state employee coverage, and Medicaid. The ADA is also grateful for the legislative leadership from bill sponsors Senator Marie Pinkney and Representative David Bentz,” said Stephen Habbe, Director, State Government Affairs. “Insulin pumps have been shown to contribute to improved control of blood glucose levels helping to prevent complications from diabetes. This law will remove the cost sharing barrier to beginning

The American Diabetes Association® (ADA) applauds Oregon Governor Kate Brown for signing legislation capping monthly copayments for insulin at $75 for those on state-regulated plans, making Oregon the 18th state, plus the District of Columbia, to enact a copay cap on the life-saving medication. State Representative Sheri Schouten from Beaverton, sponsored House Bill 2623 and through her leadership, gained overwhelming support from the entire legislative body in passing this legislation that will provide relief to many of the over 399,000 people living with diabetes in Oregon. Taking less than

Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes Findings from two studies highlight the potential for CagriSema, a dual agonist that targets both glucose regulation and appetite control, to improve weight loss in patients with and without type 2 diabetes who have overweight or obesity. The studies were presented as a late-breaking symposium at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago and simultaneously published in the New England Journal of Medicine. Nearly 90% of U.S

As a part of ADA’s Health Equity Now Platform sponsored by the Baxter International Foundation The American Diabetes Association ® (ADA) and Dion’s Chicago Dream have teamed up to provide healthy fruits and vegetables to Chicago families in the south side of Chicago. With over 3 million people living in Illinois, 34 percent having pre-diabetes and nearly 1 million people living with diabetes, this innovative way of thinking will allow more people to adopt a healthy way of eating. Many neighborhoods in the United States, particularly those in low-income areas, have been named “food deserts”